How to Prevent Ozempic Face and Sarcopenia: 6 Muscle-Centric Rules

The explosion of GLP-1 weight loss medications like Ozempic, Wegovy, and Zepbound has changed the landscape of obesity treatment forever. Millions of people are experiencing life changing results on the scale. But there is a dark side to this pharmaceutical revolution that nobody warned you about: the devastating loss of muscle mass and the haunting facial transformation known as "Ozempic face." Roughly 1 in 8 US adults have now used a GLP-1 receptor agonist, and the conversation has shifted dramatically from simple weight loss to something far more important: preserving the very tissues that keep you strong, youthful, and metabolically healthy.

If you are currently taking semaglutide, tirzepatide, or any other GLP-1 medication, or if you are considering starting one, this comprehensive guide will give you the six muscle centric rules you absolutely need to follow to prevent Ozempic face and sarcopenia. This is not about vanity. This is about protecting your long term health, your independence, and your quality of life.

What Is Ozempic Face and Why Should You Be Concerned?

"Ozempic face" is a term that has gained attention online to describe facial volume loss or skin sagging that can occur during rapid weight loss. Despite the name, this is not a direct side effect of semaglutide or GLP-1 medications but reflects a normal physiological response to losing fat, especially when weight loss happens quickly.

Ozempic Face is a term that describes gaunt and hollowed cheekbones, increased lines and wrinkles around the face, sunken eyes, dark circles around the eyes, and sagging skin around the jaw bone and neck. Overall, this causes people to look older than they actually are, and the problem is compounded by how GLP-1 drugs affect body composition during weight loss.

The Science Behind Facial Volume Loss

Facial volume comes from a combination of subcutaneous fat, collagen and elastin fibers, bone structure, and muscle tone. When weight decreases, fat is lost throughout the body, including the face.

Subcutaneous fat, which is just under your skin, is an important component of your facial structure, helping you look plump and filled in. But rapid weight loss causes you to lose subcutaneous fat from your face and neck, which causes facial hollowing and sagging skin.

Rapid weight loss lowers your levels of two proteins in the skin: elastin, which helps keep skin stretchy, and collagen, which provides support and structure. Collagen production naturally declines with age, beginning as early as the mid-20s and decreasing more rapidly after 40.

Women over 40 experience more pronounced Ozempic face because collagen production has already declined 10 to 20% from peak levels, skin elasticity is reduced, and perimenopause accelerates collagen loss.

How GLP-1 Medications Contribute to the Problem

A 2024 survey by the American Society of Dermatologic Surgery found that 58% of practitioners reported treating patients seeking facial volume restoration after GLP-1 medication use. The effect is dose dependent and time dependent: faster weight loss and longer treatment duration produce more dramatic facial changes.

What Is Sarcopenia and Why Does It Matter During Weight Loss?

Sarcopenia, defined as an age related loss in skeletal muscle mass and function, is one of the most pressing health problems in the elderly. Sarcopenia may be associated with injury, falls, bone fractures and higher rates of death.

But sarcopenia is no longer just a concern for the elderly. Rapid and significant weight loss can lead to sarcopenia, especially if you aren't focused on diet and exercise.

The Alarming Numbers on Muscle Loss

The data on muscle loss during GLP-1 therapy is deeply concerning. Semaglutide muscle loss is a documented side effect where 25 to 40% of total weight lost on GLP-1 drugs like Ozempic and Wegovy comes from lean mass rather than fat. For every 10 pounds you lose on semaglutide, 2.5 to 4 pounds may be muscle, which accelerates metabolic decline, increases injury risk, weakens bones, and contributes to the gaunt appearance known as Ozempic face.

Clinical trials have shown GLP-1 agonist drugs like semaglutide injection can lead to a 13.9% loss of lean muscle mass (equal to a 6.9 kg or 15 lb) during treatment.

A 2024 analysis in the journal Obesity found that participants on semaglutide 2.4mg lost an average of 15.3 kg total, of which 5.3 kg was lean mass. This ratio significantly exceeds the lean mass loss seen in diet and exercise only weight loss, where the typical ratio is 15 to 20% lean mass.

Of weight lost with semaglutide, approximately 45% is from lean mass, while with tirzepatide, it is 25%.

Why Muscle Loss Creates a Metabolic Trap

Muscle loss can manifest in subtle but meaningful ways: a gradual decline in strength, slower recovery from activity, reduced endurance, and increased fatigue. It can also lower the metabolic rate, making it harder to maintain weight loss in the future, as the body requires fewer calories to function.

This loss represents a major crisis because it lowers your Resting Metabolic Rate, creating a "Metabolic Rebound Effect" if the medication is discontinued.

Now that you understand the severity of the problem, let us dive into the six muscle centric rules that will protect you.

Rule 1: Prioritize High Protein Intake at Every Single Meal

The single most important thing you can do to protect your muscles while taking a GLP-1 medication is to dramatically increase your protein intake. This is non negotiable.

How Much Protein Do You Actually Need?

The average adult needs about 0.8 grams of protein per kilogram of body weight daily. For muscle preservation during weight loss, aim for 1.2 to 1.6 grams per kilogram of body weight. For example, a person weighing 70 kg (154 lbs) should consume between 84 and 112 grams of protein daily.

Consuming 1.2 to 1.6 grams of protein per kilogram of body weight daily reduces muscle wasting and indirectly supports facial structure.

Aim for 20 to 30 grams of protein at each meal, or 1 to 1.5 grams of protein per kilogram of body weight daily.

The Protein Timing Secret

A 7 day crossover feeding study showed that distributing protein evenly across meals (approximately 25 to 30 g per breakfast, lunch, and dinner) increased muscle protein synthesis by 25% compared with a skewed intake pattern.

This means that eating all your protein in one meal is far less effective than spreading it throughout the day. Each meal should contain a meaningful serving of high quality protein.

Best Protein Sources for GLP-1 Users

Good sources of protein include lean meats such as fish, beef, or poultry; eggs; nuts and seeds; tofu; and legumes such as beans and lentils.

Because GLP-1 medications significantly reduce your appetite, getting enough protein becomes a genuine challenge. The appetite suppression mechanism of GLP-1 drugs reduces total caloric intake without preference for macronutrient composition, meaning many users undereat protein during treatment. Semaglutide suppresses appetite at the brain level, reducing caloric intake by 25 to 35% on average.

Consider protein supplements like whey or plant based powders if meeting needs through food is difficult. Liquid protein sources like shakes, bone broth, and Greek yogurt smoothies can be especially helpful when your appetite is suppressed.

Clinical Evidence Supporting High Protein Strategies

The Health ABC Study, a three year longitudinal analysis in 2066 community dwelling older adults aged 70 to 79, found that those in the highest quintile of protein intake lost nearly 40% less lean mass than those in the lowest quintile, even after adjusting for confounders.

In a randomized controlled trial involving young adults undergoing marked energy restriction and resistance exercise training, a higher protein diet (2.4 g/kg/day) led to greater increases in lean body mass and greater fat mass loss compared with a lower protein diet.

Rule 2: Commit to Structured Resistance Training at Least 3 Days Per Week

Protein alone will not save your muscles. You must combine adequate protein intake with consistent resistance training. As resistance training is considered the most potent nonpharmacological stimulus for attenuating muscle loss and inducing skeletal muscle growth, it may be worthy of particular focus.

Why Resistance Training Is Non Negotiable

Exercise, particularly resistance training, is crucial for preserving lean mass and functional health, especially during weight loss. Direct comparisons reveal that GLP-1 receptor agonists generally produce greater short term weight loss than exercise alone, but exercise is superior for maintaining lean mass and cardiorespiratory fitness.

Studies show that resistance training at least 3 days per week can reduce lean mass loss during GLP-1 treatment from 40% to under 20% of total weight lost.

The Ideal Resistance Training Program

Aim for 2 to 3 sessions per week targeting all major muscle groups. Focus on compound movements like squats, lunges, push ups, rows, and deadlifts. Use weights or resistance that challenge you but allow proper form.

Here is a sample weekly resistance training schedule for GLP-1 medication users:

Day 1: Lower Body Focus Squats, lunges, leg press, Romanian deadlifts, calf raises

Day 2: Upper Body Push Bench press, overhead press, push ups, tricep dips, lateral raises

Day 3: Upper Body Pull and Core Rows, pull ups or lat pulldowns, bicep curls, face pulls, planks

Day 4 (Optional): Full Body Deadlifts, step ups, chest press, seated rows, farmer carries

The Evidence for Combined Approaches

Current data shows combining a high protein diet and consistent exercise with GLP-1 treatment has the greatest benefit in preserving bone and muscle mass, compared to diet alone or high protein diet alone. Patients who engage in regular exercise at initiation and throughout their treatment have the best chances of preserving lean body mass.

Recent randomized controlled trials show that combining GLP-1 receptor agonists with exercise yields additive benefits, including greater reductions in metabolic syndrome severity, abdominal obesity, oxidative stress and inflammation, and improved weight loss maintenance after cessation of pharmacotherapy.

Rule 3: Slow Down Your Rate of Weight Loss

One of the most counterintuitive yet critically important rules is to resist the temptation to lose weight as fast as possible. Rapid weight loss is the primary driver of both Ozempic face and accelerated muscle breakdown.

Why Slower Is Better

To try to prevent facial changes associated with rapid weight loss, consider a more gradual approach instead. Experts recommend focusing on slower weight loss, about one to two pounds per week.

The speed of weight loss influences how effectively the skin adjusts. Research shows that rapid weight loss is associated with greater skin laxity compared to gradual weight reduction.

If the rate of fat loss outpaces collagen remodeling, visible sagging can occur.

How to Manage Your Weight Loss Speed

Work closely with your prescribing physician to manage your medication dosage. Maintain high protein intake, perform resistance training 3 or more days per week, and discuss dose titration with your prescriber to slow the rate of loss.

You can minimize these side effects by using your medication in combination with a healthy diet and exercise regimen.

Consider the following strategies to moderate your weight loss pace:

1. Gradual dose escalation rather than jumping quickly to the maximum dose

2. Monitoring body composition rather than just total body weight

3. Setting realistic timelines that prioritize muscle preservation over speed

4. Regular check ins with your healthcare provider to adjust dosing as needed

Rule 4: Supplement Strategically With Creatine, Collagen, and Key Nutrients

While whole foods should form the foundation of your nutrition strategy, targeted supplementation can provide an additional layer of muscle protection during GLP-1 therapy.

Creatine Monohydrate: The Proven Muscle Protector

Creatine monohydrate at 5 grams daily supports muscle energy during resistance training and has evidence for lean mass preservation during caloric restriction. While not studied specifically with GLP-1 drugs, creatine's mechanism of increasing intramuscular phosphocreatine stores directly supports the training intensity needed to preserve muscle.

Creatine is no longer just for bodybuilders; experts now recognize it as a supplement for cognitive performance and bone density as well.

Collagen for Skin and Structural Support

Vitamin C, zinc, copper, and adequate overall caloric intake support collagen synthesis. Some research suggests collagen supplementation may modestly improve skin elasticity over time, particularly in aging populations.

Topical retinoids and vitamin C serums support collagen maintenance from the outside.

Essential Micronutrients You Cannot Ignore

Protein provides amino acids necessary for collagen production and tissue repair. During weight loss, adequate protein intake supports muscle preservation and overall structural integrity.

Key supplements to consider during GLP-1 treatment:

SupplementDosagePurposeCreatine Monohydrate5g dailyMuscle energy and preservationCollagen Peptides10 to 15g dailySkin elasticity and joint supportVitamin C500 to 1000mg dailyCollagen synthesisVitamin D2000 to 4000 IU dailyBone and muscle healthOmega 3 Fatty Acids2 to 3g dailyAnti inflammatory supportZinc15 to 30mg dailyTissue repair and immune function

Branched Chain Amino Acids and Leucine

Branched chain amino acids, creatine, and leucine are among the nutrients that have been suggested as supplementary options when dietary measures alone are insufficient to maintain muscle mass during GLP-1 treatment.

Rule 5: Hydrate Aggressively and Protect Your Skin

Hydration is often underestimated in its importance during GLP-1 therapy, but it plays a crucial role in both muscle function and skin health.

Hydration and Muscle Preservation

Staying hydrated helps your skin stay elastic. But hydration does far more than just help your skin. Adequate water intake supports nutrient delivery to muscle tissue, helps maintain exercise performance, and supports the metabolic processes that keep your muscles functioning optimally.

Dehydration can exaggerate the appearance of fine lines and skin laxity. Maintaining fluid intake supports skin turgor and elasticity. Semaglutide can reduce appetite and sometimes thirst cues, so intentional hydration becomes important.

Comprehensive Skin Care Strategies

Establishing and sticking to a good skin care routine is essential. Choose the right sunscreen and wear it daily.

For those already experiencing or wanting to prevent Ozempic face, a comprehensive skincare approach should include:

1. Daily broad spectrum SPF 30+ sunscreen to prevent further collagen breakdown

2. Retinol or retinoid products to stimulate collagen production

3. Vitamin C serum applied topically for antioxidant protection

4. Hyaluronic acid moisturizer to help skin retain moisture

5. Gentle cleansing that does not strip the skin's natural barrier

Medical Aesthetic Options

For existing Ozempic face, hyaluronic acid fillers like Juvederm Voluma and Restylane Lyft can restore volume to depleted fat compartments. Some dermatologists recommend starting preventive filler before significant weight loss begins.

These options should be discussed with a qualified dermatologist or plastic surgeon who has experience treating patients undergoing significant weight loss.

Rule 6: Monitor Your Body Composition, Not Just the Scale

The bathroom scale is the worst possible tool for measuring your progress during GLP-1 therapy. It tells you nothing about whether you are losing fat or muscle. The traditional "calories in vs. calories out" model has been replaced by "Weight Loss Quality," where maintaining muscle is the primary pillar of metabolic health.

DXA Scans: The Gold Standard

Whether you are working out or waiting on your latest DXA scan results, the objective in 2026 is clear. Advanced strategies like protein pacing and the anatomical precision of a DXA scan (Dual energy X ray Absorptiometry) are essential for navigating this pharmacological revolution.

A DXA scan provides detailed information about your fat mass, lean mass, and bone density. This allows you and your healthcare provider to track whether your weight loss is coming primarily from fat, which is the goal, or from muscle, which signals a need for intervention.

How Often Should You Monitor?

Experts recommend getting a baseline DXA scan before starting GLP-1 therapy, and then follow up scans every 3 to 6 months during treatment. This allows you to:

1. Track your fat to lean mass ratio over time

2. Identify early signs of excessive muscle loss

3. Adjust your nutrition and exercise strategy accordingly

4. Provide objective data to your healthcare provider

Other Body Composition Tools

If DXA scans are not accessible or affordable, other options include:

Bioelectrical Impedance Analysis (BIA): Available through many smart scales and gym equipment. Less accurate than DXA but useful for tracking trends over time.

Handgrip Strength Testing: A simple, inexpensive measure of functional muscle strength. Appropriate measures to assess lean mass and functionality include dual energy X ray absorptiometry, nitrogen balance, or handgrip strength.

Progress Photos and Measurements: While subjective, these can help you visually track changes in body composition.

The Future of Muscle Preservation: Breakthrough Drugs in Development

The pharmaceutical industry has recognized the muscle loss problem and is actively developing solutions. Several groundbreaking medications are in clinical trials that could revolutionize how we approach weight loss in the coming years.

Bimagrumab: The Muscle Sparing Antibody

Bimagrumab is a mid stage antibody that targets activin/myostatin type II receptors, which are involved in signaling cascades that counteract muscle growth. Bimagrumab's mechanism not only prevents muscle loss but can also promote an increase in muscle.

Data from the Phase IIb BELIEVE trial demonstrated that bimagrumab, when used with semaglutide, can lower body weight by 22.1% at 72 weeks. Notably, 92.8% of this weight loss is attributable to fat, meaning only around 7% was due to the wasting of lean mass.

This is a dramatic improvement over semaglutide alone, where lean mass can account for up to 40% of total weight lost.

Bimagrumab is still currently being studied in an ongoing phase 2 trial with tirzepatide, alone or in combination, in patients with obesity. Results from this trial will be available in 2026.

Other Promising Compounds

Regeneron released Phase II data for the investigational antibody trevogrumab, touting a 51.3% boost in muscle preservation versus semaglutide monotherapy. Adding on another therapy, dubbed garetosmab, increased preserved muscle to 80.9% relative to semaglutide. Scholar Rock announced that apitegromab, when used alongside tirzepatide, preserves 55% more muscle mass than tirzepatide alone.

Interim findings from the phase 2 COURAGE trial indicate that co administration of semaglutide with trevogrumab and garetosmab produces synergistic effects on body composition, markedly enhancing fat loss while preserving lean mass compared with semaglutide monotherapy.

A Continuous Protein Sensor for Sarcopenia Management

A new study demonstrates proof of concept for a continuous protein sensor as a tool to prevent muscle loss during GLP-1 therapy. "GLP-1 medications have transformed the treatment of diabetes and obesity, but they can also increase the risk of muscle loss," explained the lead author. "While patients are advised to consume more protein to preserve muscle, it's often difficult to know if they're getting enough."

Expert Insights: What Top Doctors Are Saying in 2026

The medical community has increasingly focused on the quality of weight loss rather than just the quantity. "As we enter a new era of obesity treatments, it's vital to focus not just on the amount of weight lost, but on preserving muscle mass and gaining the health benefits that result from treating obesity."

"It's not related to how the drug works itself," explains obesity medicine specialist W. Scott Butsch, MD. "Muscle loss is related to the process of losing weight."

"It's important to allay fears and provide reassurance that some lean body mass loss is a part of the weight loss journey, and we have tools to help."

The message from researchers is clear: nutrition must no longer remain a missing pillar in obesity management medication care.

Who Is Most at Risk for Ozempic Face and Sarcopenia?

Not everyone experiences these side effects equally. Understanding your personal risk factors can help you take more targeted preventive action.

Higher Risk Groups

Women and older adults with obesity may lose more muscle mass than other groups.

Depending on the definition used for sarcopenia, the prevalence in 60 to 70 year olds is reported to be between 6% and 22%, while the prevalence is as high as 50% in people over 80 years old.

Sarcopenic obesity, a subtype of obesity, is marked by reduced skeletal muscle mass and function, and poses a significant health challenge to older adults as it affects an estimated 28.3% of people aged over 60 years. This subtype is unique to older adults as aging exacerbates sarcopenia and obesity due to changes in energy metabolism, hormones and inflammatory markers, and lifestyle factors.

Those at highest risk include:

1. Adults over 50: Age related muscle decline accelerates the problem

2. Women in perimenopause or menopause: Hormonal changes compound muscle and collagen loss

3. People with sedentary lifestyles: Lack of physical activity worsens muscle atrophy

4. Those with low baseline protein intake: Starting from a deficit makes preservation harder

5. Individuals on high doses: Faster weight loss and longer treatment duration produce more dramatic changes

6. Super responders: People who lose weight exceptionally fast on GLP-1 medications

Practical Meal Plan for Muscle Preservation on GLP-1 Medications

Since appetite suppression is one of the primary challenges, here is a practical approach to getting enough protein and nutrients even when you do not feel hungry.

Sample Day of Eating (Target: 120g Protein)

Breakfast (30g protein) Greek yogurt parfait with whey protein powder, berries, and a handful of almonds

Mid Morning Snack (15g protein) Protein shake or collagen enhanced coffee with milk

Lunch (30g protein) Grilled chicken salad with quinoa, avocado, and mixed vegetables

Afternoon Snack (15g protein) Cottage cheese with pumpkin seeds or a protein bar

Dinner (30g protein) Baked salmon with roasted sweet potatoes and steamed broccoli

Tips for Eating Enough When You Have No Appetite

Include protein with every meal and snack. Choose high quality protein sources such as lean meats, fish, eggs, dairy, legumes, and plant based proteins.

1. Eat protein first at every meal before filling up on other foods

2. Use liquid calories wisely with protein shakes and smoothies

3. Set reminders to eat at regular intervals even when not hungry

4. Choose nutrient dense foods that pack maximum nutrition into small portions

5. Prepare meals in advance so healthy options are always available

The Bottom Line: Your 6 Rule Action Plan

Let us summarize the six muscle centric rules that will protect you from Ozempic face and sarcopenia:

RuleActionTargetRule 1High protein intake1.2 to 1.6g per kg body weight dailyRule 2Resistance training3 or more sessions per weekRule 3Slow weight loss pace1 to 2 pounds per weekRule 4Strategic supplementationCreatine 5g, collagen, Vitamin C, DRule 5Aggressive hydration and skin care8+ glasses water, daily SPFRule 6Body composition monitoringDXA scan every 3 to 6 months

GLP-1 receptor agonist therapy for obesity should include resistance training, optimal protein intake and, if needed, specific nutrients and possibly pharmacological interventions to preserve muscle mass.

Muscle loss is not inevitable when using GLP-1 medications. With the right protein intake and strength training routine, you can protect your muscle mass and enjoy the health benefits of your treatment.

The realistic goal during GLP-1 treatment is muscle preservation, not growth. After reaching your target weight and transitioning off or to a maintenance dose, muscle building becomes feasible with adequate caloric intake and progressive resistance training.

When to Talk to Your Doctor

You should have an open conversation with your healthcare provider about muscle preservation before starting GLP-1 therapy and at regular intervals throughout your treatment. If you are starting treatment with a GLP-1 agonist, speak with your healthcare provider about preventing muscle loss with a resistance training program. Also consider meeting with a registered dietitian who can provide information on how much protein you should eat per day, your need for supplemental vitamins, and other nutritional strategies to help retain muscle mass and function.

Red flags that require immediate medical attention include:

1. Rapid, unexplained loss of strength

2. Difficulty performing daily activities you previously managed easily

3. Severe facial hollowing or skin changes

4. Falls, balance issues, or coordination problems

5. Extreme fatigue or weakness during normal activities

Conclusion: Redefining Success in the Age of Weight Loss Medications

The weight loss medication revolution is here to stay. Patients using GLP-1 medications can experience muscle loss alongside fat loss if active steps are not taken. While these medications have redefined what is possible in weight management, their effectiveness can come with the unintended consequence of losing muscle mass if no structured plan is in place.

The "skinny" goal is being replaced by the "functional" goal. Success in 2026 is not about a number on the scale. It is about losing fat while keeping muscle. It is about looking healthy, not gaunt. It is about being stronger, not just lighter.

By following these six muscle centric rules, you can take full advantage of the remarkable weight loss benefits of GLP-1 medications while protecting the muscle, skin, and metabolic health that make your transformation truly successful.

Your muscles are your metabolic engine. Your facial structure is your identity. Do not sacrifice them on the altar of rapid weight loss. Be strategic. Be patient. Be muscle centric.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with your healthcare provider before starting any medication, supplement, or exercise program. Individual results may vary based on personal health conditions, genetics, and adherence to recommended protocols.

Sources and References

1. Cleveland Clinic: "'Ozempic Face': What It Is and How to Avoid It" — https://health.clevelandclinic.org/ozempic-face

2. Health Highroad: "Semaglutide Muscle Loss: How to Keep Lean Mass" — https://www.healthhighroad.com/womens-health/healthy-living/semaglutide-muscle-loss-prevention/78095

3. Enhance.MD: "Ozempic Face Explained" — https://enhance.md/blog/ozempic-face

4. Drugs.com: "Does Ozempic cause muscle loss and how to prevent it?" — https://www.drugs.com/medical-answers/ozempic-cause-muscle-loss-how-you-prevent-3578660/

5. Drugs.com: "Ozempic Face: What causes it and how to prevent it?" — https://www.drugs.com/medical-answers/ozempic-face-3572731/

6. Cleveland Clinic: "Ozempic and Muscle Loss: What To Know" — https://health.clevelandclinic.org/ozempic-muscle-loss

7. ScienceDirect: "Optimizing GLP-1 therapies for obesity and diabetes management" — https://www.sciencedirect.com/science/article/pii/S266736812500066X

8. PMC: "Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists" — https://pmc.ncbi.nlm.nih.gov/articles/PMC12536186/

9. International Journal of Obesity: "Bridging the nutrition guidance gap for GLP-1 receptor agonist therapy" — https://www.nature.com/articles/s41366-025-01952-w

10. Frontiers: "GLP-1 agonists and exercise: the future of lifestyle prioritization" — https://www.frontiersin.org/journals/clinical-diabetes-and-healthcare/articles/10.3389/fcdhc.2025.1720794/full

11. Mass General Advances in Motion: "Preserving Lean Body Mass in Patients Taking GLP-1 for Weight Loss" — https://advances.massgeneral.org/endocrinology/article.aspx?id=1601

12. American Diabetes Association: "New GLP-1 Therapies Enhance Quality of Weight Loss" — https://diabetes.org/newsroom/press-releases/new-glp-1-therapies-enhance-quality-weight-loss-improving-muscle-0

13. Health Highroad: "Ozempic Face: Why GLP-1 Drugs Age Your Face" — https://www.healthhighroad.com/disease-medicine/ozempic-face-glp1-facial-aging/78044

14. BioSpace: "Obesity in Focus: ADA Reveals R&D Priorities" — https://www.biospace.com/drug-development/obesity-in-focus-ada-reveals-r-d-priorities-for-blockbusters-in-waiting

15. Diabetes Journal (ADA): "Treating Sarcopenic Obesity in the Era of Incretin Therapies" — https://diabetesjournals.org/diabetes/article/74/12/2179/160535

16. Self London: "How to Prevent Muscle Loss on Ozempic & GLP-1 Medications" — https://selflondon.com/how-to-prevent-muscle-loss-while-taking-ozempic-and-glp-1-medications/